Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000011504 | SCV001416340 | pathogenic | Fabry disease | 2023-03-01 | criteria provided, single submitter | clinical testing | This variant, c.1212_1214del, results in the deletion of 1 amino acid(s) of the GLA protein (p.Arg404del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with Fabry disease (PMID: 7504405, 9100224, 15091117, 25386848). It has also been observed to segregate with disease in related individuals. This variant is also known as 1209del3 or 1208del3. Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects GLA function (PMID: 26415523). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV001781219 | SCV002018435 | likely pathogenic | not provided | 2021-02-08 | criteria provided, single submitter | clinical testing | |
Ai |
RCV001781219 | SCV002501064 | likely pathogenic | not provided | 2021-05-26 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000011504 | SCV000031736 | pathogenic | Fabry disease | 1993-12-01 | no assertion criteria provided | literature only |